Labcorp Holdings Inc (LH)
238.64
+3.43
(+1.46%)
USD |
NYSE |
Nov 18, 16:00
238.72
+0.08
(+0.03%)
After-Hours: 20:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 19.96B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 13.86% |
| Valuation | |
| PE Ratio | 46.34 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 1.590 |
| Price to Book Value | 2.443 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.72 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.8264 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 46.58% |
Profile
| Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing. |
| URL | https://www.labcorp.com |
| Investor Relations URL | https://ir.labcorp.com |
| HQ State/Province | North Carolina |
| Sector | Health Care |
| Industry | Health Care Providers & Services |
| Equity Style | Mid Cap/Value |
| Next Earnings Release | Feb. 14, 2025 (est.) |
| Last Earnings Release | Oct. 24, 2024 |
| Next Ex-Dividend Date | Nov. 26, 2024 |
| Last Ex-Dividend Date | Aug. 29, 2024 |
Ratings
Profile
| Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing. |
| URL | https://www.labcorp.com |
| Investor Relations URL | https://ir.labcorp.com |
| HQ State/Province | North Carolina |
| Sector | Health Care |
| Industry | Health Care Providers & Services |
| Equity Style | Mid Cap/Value |
| Next Earnings Release | Feb. 14, 2025 (est.) |
| Last Earnings Release | Oct. 24, 2024 |
| Next Ex-Dividend Date | Nov. 26, 2024 |
| Last Ex-Dividend Date | Aug. 29, 2024 |